CAR T treatments could have fewer side effects than other cancer immunotherapies
Wednesday, January 29, 2020 - 09:30
in Health & Medicine
New cancer immunotherapies involve extracting a patient's T cells and genetically engineering them so they will recognize and attack tumors. This technique is a true medical breakthrough, with an increasing number of leukemia and lymphoma patients experiencing complete remissions since CAR T therapy was FDA approved in 2017.